|
|
dna repair
|
GO:0006281 |
54 |
0.999
|
|
|
|
double strand break repair
|
GO:0006302 |
26 |
0.999
|
|
|
|
dna recombination
|
GO:0006310 |
32 |
0.999
|
|
|
|
double strand break repair via homologous recombination
|
GO:0000724 |
13 |
0.998
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
223 |
0.998
|
|
|
|
double strand break repair via nonhomologous end joining
|
GO:0006303 |
5 |
0.998
|
|
|
|
double strand break repair via synthesis dependent strand annealing
|
GO:0045003 |
6 |
0.996
|
|
|
|
non recombinational repair
|
GO:0000726 |
7 |
0.991
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
74 |
0.984
|
|
|
|
recombinational repair
|
GO:0000725 |
13 |
0.982
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
78 |
0.981
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
75 |
0.979
|
|
|
|
nucleotide excision repair
|
GO:0006289 |
8 |
0.975
|
|
|
|
dna synthesis involved in dna repair
|
GO:0000731 |
5 |
0.968
|
|
|
|
dna double strand break processing
|
GO:0000729 |
3 |
0.866
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
88 |
0.793
|
|
|
|
postreplication repair
|
GO:0006301 |
2 |
0.744
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
138 |
0.741
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
103 |
0.731
|
|
|
|
mitotic g2 dna damage checkpoint
|
GO:0007095 |
69 |
0.719
|
|
|
|
response to radiation
|
GO:0009314 |
155 |
0.714
|
|
|
|
dna metabolic process
|
GO:0006259 |
227 |
0.685
|
|
|
|
mitotic g2 m transition checkpoint
|
GO:0044818 |
70 |
0.685
|
|
|
|
mitotic recombination
|
GO:0006312 |
2 |
0.657
|
|
|
|
telomere maintenance via recombination
|
GO:0000722 |
1 |
0.652
|
|
|
|
translesion synthesis
|
GO:0019985 |
2 |
0.645
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
109 |
0.589
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
81 |
0.588
|
|
|
|
telomere maintenance
|
GO:0000723 |
21 |
0.584
|
|
|
|
meiosis i
|
GO:0007127 |
59 |
0.566
|
|
|
|
reciprocal meiotic recombination
|
GO:0007131 |
19 |
0.564
|
|
|
|
response to uv
|
GO:0009411 |
24 |
0.561
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
32 |
0.557
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
151 |
0.532
|
|
|
|
telomere organization
|
GO:0032200 |
21 |
0.516
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
109 |
0.511
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
132 |
0.508
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
95 |
0.480
|
|
|
|
g2 dna damage checkpoint
|
GO:0031572 |
69 |
0.480
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
59 |
0.473
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
130 |
0.470
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
103 |
0.454
|
|
|
|
chromosome organization
|
GO:0051276 |
360 |
0.443
|
|
|
|
cellular response to radiation
|
GO:0071478 |
52 |
0.421
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
116 |
0.392
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
89 |
0.372
|
|
|
|
regulation of dna recombination
|
GO:0000018 |
4 |
0.369
|
|
|
|
regulation of dna repair
|
GO:0006282 |
5 |
0.347
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
90 |
0.346
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
24 |
0.343
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
181 |
0.342
|
|
|
|
response to alkaloid
|
GO:0043279 |
26 |
0.322
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
11 |
0.306
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
155 |
0.289
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
75 |
0.276
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
140 |
0.274
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
130 |
0.269
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
108 |
0.261
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
127 |
0.258
|
|
|
|
response to light stimulus
|
GO:0009416 |
124 |
0.238
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
112 |
0.237
|
|
|
|
dna geometric change
|
GO:0032392 |
16 |
0.228
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
23 |
0.223
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
108 |
0.206
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
190 |
0.201
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
171 |
0.201
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
127 |
0.199
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
112 |
0.197
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
120 |
0.190
|
|
|
|
nucleobase containing compound catabolic process
|
GO:0034655 |
165 |
0.176
|
|
|
|
organelle fission
|
GO:0048285 |
340 |
0.172
|
|
|
|
aging
|
GO:0007568 |
143 |
0.172
|
|
|
|
phosphorylation
|
GO:0016310 |
294 |
0.171
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
50 |
0.171
|
|
|
|
response to organic substance
|
GO:0010033 |
284 |
0.162
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
108 |
0.159
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
119 |
0.157
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
200 |
0.155
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
341 |
0.152
|
|
|
|
organophosphate metabolic process
|
GO:0019637 |
195 |
0.146
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
112 |
0.145
|
|
|
|
atp metabolic process
|
GO:0046034 |
49 |
0.144
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
291 |
0.141
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
127 |
0.140
|
|
|
|
cellular protein modification process
|
GO:0006464 |
438 |
0.139
|
|
|
|
homeostatic process
|
GO:0042592 |
199 |
0.138
|
|
|
|
reciprocal dna recombination
|
GO:0035825 |
19 |
0.138
|
|
|
|
response to endogenous stimulus
|
GO:0009719 |
119 |
0.137
|
|
|
|
regulation of double strand break repair
|
GO:2000779 |
3 |
0.134
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
109 |
0.132
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
140 |
0.131
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
108 |
0.129
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
168 |
0.128
|
|
|
|
cellular catabolic process
|
GO:0044248 |
372 |
0.125
|
|
|
|
protein phosphorylation
|
GO:0006468 |
169 |
0.123
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
10 |
0.123
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
109 |
0.123
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
145 |
0.123
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
146 |
0.120
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
109 |
0.118
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
119 |
0.116
|
|
|
|
death
|
GO:0016265 |
284 |
0.116
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
112 |
0.115
|
|
|
|
chromatin organization
|
GO:0006325 |
207 |
0.115
|
|
|
|
organonitrogen compound metabolic process
|
GO:1901564 |
318 |
0.114
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
174 |
0.111
|
|
|
|
growth
|
GO:0040007 |
359 |
0.110
|
|
|
|
immune system process
|
GO:0002376 |
347 |
0.109
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
109 |
0.108
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
110 |
0.106
|
|
|
|
chromosome segregation
|
GO:0007059 |
157 |
0.105
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
127 |
0.104
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
127 |
0.103
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
51 |
0.101
|
|
|
|
positive regulation of macromolecule biosynthetic process
|
GO:0010557 |
283 |
0.100
|
|
|
|
response to x ray
|
GO:0010165 |
8 |
0.098
|
|
|
|
positive regulation of rna biosynthetic process
|
GO:1902680 |
266 |
0.096
|
|
|
|
negative regulation of nitrogen compound metabolic process
|
GO:0051172 |
265 |
0.095
|
|
|
|
carbohydrate derivative metabolic process
|
GO:1901135 |
217 |
0.094
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
162 |
0.092
|
|
|
|
small molecule metabolic process
|
GO:0044281 |
305 |
0.090
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
3 |
0.090
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
166 |
0.089
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
118 |
0.088
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
166 |
0.086
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
145 |
0.085
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
161 |
0.084
|
|
|
|
negative regulation of response to stimulus
|
GO:0048585 |
258 |
0.083
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
128 |
0.082
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
119 |
0.081
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
97 |
0.080
|
|
|
|
catabolic process
|
GO:0009056 |
409 |
0.080
|
|
|
|
response to caffeine
|
GO:0031000 |
12 |
0.080
|
|
|
|
cell death
|
GO:0008219 |
279 |
0.080
|
|
|
|
negative regulation of cell communication
|
GO:0010648 |
223 |
0.078
|
|
|
|
organic substance catabolic process
|
GO:1901575 |
308 |
0.077
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
112 |
0.076
|
|
|
|
oocyte fate determination
|
GO:0030716 |
27 |
0.075
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
165 |
0.075
|
|
|
|
regulation of programmed cell death
|
GO:0043067 |
152 |
0.075
|
|
|
|
cellular response to chemical stimulus
|
GO:0070887 |
199 |
0.074
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
302 |
0.073
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
38 |
0.073
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
23 |
0.071
|
|
|
|
dna replication
|
GO:0006260 |
48 |
0.070
|
|
|
|
regulation of response to stress
|
GO:0080134 |
200 |
0.068
|
|
|
|
hemopoiesis
|
GO:0030097 |
46 |
0.068
|
|
|
|
cellular response to organic substance
|
GO:0071310 |
132 |
0.068
|
|
|
|
dna catabolic process
|
GO:0006308 |
16 |
0.067
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
112 |
0.067
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
23 |
0.066
|
|
|
|
female meiotic division
|
GO:0007143 |
70 |
0.066
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
16 |
0.065
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
112 |
0.065
|
|
|
|
intracellular signal transduction
|
GO:0035556 |
300 |
0.065
|
|
|
|
single organism catabolic process
|
GO:0044712 |
228 |
0.064
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
34 |
0.063
|
|
|
|
cell aging
|
GO:0007569 |
2 |
0.063
|
|
|
|
cellular macromolecule localization
|
GO:0070727 |
220 |
0.061
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
36 |
0.060
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
58 |
0.060
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
38 |
0.059
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
13 |
0.059
|
|
|
|
apoptotic process
|
GO:0006915 |
159 |
0.058
|
|
|
|
regulation of cellular protein metabolic process
|
GO:0032268 |
243 |
0.057
|
|
|
|
developmental growth
|
GO:0048589 |
280 |
0.057
|
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
15 |
0.057
|
|
|
|
body morphogenesis
|
GO:0010171 |
2 |
0.056
|
|
|
|
single organism biosynthetic process
|
GO:0044711 |
206 |
0.056
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
52 |
0.056
|
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
79 |
0.055
|
|
|
|
positive regulation of nucleic acid templated transcription
|
GO:1903508 |
266 |
0.054
|
|
|
|
regulation of cell death
|
GO:0010941 |
173 |
0.054
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
50 |
0.053
|
|
|
|
protein modification process
|
GO:0036211 |
438 |
0.051
|
|
|
|
positive regulation of cellular biosynthetic process
|
GO:0031328 |
316 |
0.045
|
|
|
|
immune response
|
GO:0006955 |
246 |
0.045
|
|
|
|
dna dependent dna replication
|
GO:0006261 |
17 |
0.045
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
213 |
0.044
|
|
|
|
regulation of phosphorylation
|
GO:0042325 |
147 |
0.044
|
|
|
|
programmed cell death
|
GO:0012501 |
257 |
0.043
|
|
|
|
neurological system process
|
GO:0050877 |
358 |
0.043
|
|
|
|
atp catabolic process
|
GO:0006200 |
38 |
0.042
|
|
|
|
negative regulation of cellular metabolic process
|
GO:0031324 |
382 |
0.042
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
179 |
0.041
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
137 |
0.041
|
|
|
|
positive regulation of rna metabolic process
|
GO:0051254 |
271 |
0.041
|
|
|
|
response to purine containing compound
|
GO:0014074 |
12 |
0.040
|
|
|
|
regulation of system process
|
GO:0044057 |
36 |
0.039
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
143 |
0.038
|
|
|
|
regulation of multicellular organismal development
|
GO:2000026 |
414 |
0.038
|
|
|
|
single organism intracellular transport
|
GO:1902582 |
207 |
0.037
|
|
|
|
positive regulation of multicellular organismal process
|
GO:0051240 |
143 |
0.036
|
|
|
|
polarity specification of dorsal ventral axis
|
GO:0009951 |
6 |
0.035
|
|
|
|
immune system development
|
GO:0002520 |
57 |
0.035
|
|
|
|
regulation of molecular function
|
GO:0065009 |
217 |
0.034
|
|
|
|
positive regulation of transcription dna templated
|
GO:0045893 |
266 |
0.034
|
|
|
|
positive regulation of nitrogen compound metabolic process
|
GO:0051173 |
354 |
0.034
|
|
|
|
eye development
|
GO:0001654 |
323 |
0.034
|
|
|
|
dorsal ventral pattern formation
|
GO:0009953 |
133 |
0.033
|
|
|
|
regulation of phosphorus metabolic process
|
GO:0051174 |
210 |
0.033
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
13 |
0.033
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
116 |
0.033
|
|
|
|
positive regulation of signaling
|
GO:0023056 |
243 |
0.033
|
|
|
|
meiotic chromosome separation
|
GO:0051307 |
8 |
0.033
|
|
|
|
positive regulation of biosynthetic process
|
GO:0009891 |
316 |
0.033
|
|
|
|
regionalization
|
GO:0003002 |
416 |
0.032
|
|
|
|
cell proliferation
|
GO:0008283 |
299 |
0.032
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
31 |
0.032
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
81 |
0.031
|
|
|
|
transmembrane transport
|
GO:0055085 |
139 |
0.031
|
|
|
|
negative regulation of signal transduction
|
GO:0009968 |
206 |
0.031
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
73 |
0.031
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
3 |
0.030
|
|
|
|
regulation of protein metabolic process
|
GO:0051246 |
256 |
0.030
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
51 |
0.030
|
|
|
|
positive regulation of nucleobase containing compound metabolic process
|
GO:0045935 |
332 |
0.029
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
57 |
0.029
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
61 |
0.029
|
|
|
|
regulation of protein modification process
|
GO:0031399 |
112 |
0.029
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
145 |
0.028
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
62 |
0.028
|
|
|
|
transcription from rna polymerase ii promoter
|
GO:0006366 |
368 |
0.028
|
|
|
|
nuclear division
|
GO:0000280 |
332 |
0.028
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
96 |
0.028
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
130 |
0.028
|
|
|
|
establishment of localization in cell
|
GO:0051649 |
402 |
0.028
|
|
|
|
regulation of developmental growth
|
GO:0048638 |
174 |
0.027
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
69 |
0.027
|
|
|
|
histone modification
|
GO:0016570 |
106 |
0.027
|
|
|
|
wing disc morphogenesis
|
GO:0007472 |
344 |
0.027
|
|
|
|
carboxylic acid metabolic process
|
GO:0019752 |
92 |
0.027
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
136 |
0.026
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
41 |
0.026
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter
|
GO:0045944 |
204 |
0.026
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
152 |
0.025
|
|
|
|
germarium derived egg chamber formation
|
GO:0007293 |
101 |
0.025
|
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
39 |
0.025
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
89 |
0.025
|
|
|
|
cell motility
|
GO:0048870 |
251 |
0.025
|
|
|
|
amine metabolic process
|
GO:0009308 |
12 |
0.025
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
53 |
0.025
|
|
|
|
positive regulation of cell communication
|
GO:0010647 |
250 |
0.024
|
|
|
|
organelle assembly
|
GO:0070925 |
198 |
0.024
|
|
|
|
regulation of intracellular signal transduction
|
GO:1902531 |
236 |
0.024
|
|
|
|
regulation of catalytic activity
|
GO:0050790 |
185 |
0.024
|
|
|
|
response to camptothecin
|
GO:1901563 |
2 |
0.023
|
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
60 |
0.022
|
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
39 |
0.022
|
|
|
|
compound eye development
|
GO:0048749 |
307 |
0.021
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
24 |
0.021
|
|
|
|
anterior posterior pattern specification
|
GO:0009952 |
136 |
0.021
|
|
|
|
regulation of synaptic transmission
|
GO:0050804 |
69 |
0.021
|
|
|
|
negative regulation of signaling
|
GO:0023057 |
219 |
0.021
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
106 |
0.021
|
|
|
|
mitotic dna replication checkpoint
|
GO:0033314 |
5 |
0.021
|
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
60 |
0.020
|
|
|
|
positive regulation of signal transduction
|
GO:0009967 |
223 |
0.020
|
|
|
|
axonogenesis
|
GO:0007409 |
290 |
0.020
|
|
|
|
regulation of phosphate metabolic process
|
GO:0019220 |
210 |
0.020
|
|
|
|
negative regulation of biosynthetic process
|
GO:0009890 |
277 |
0.020
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
31 |
0.020
|
|
|
|
karyosome formation
|
GO:0030717 |
22 |
0.019
|
|
|
|
positive regulation of gene expression
|
GO:0010628 |
290 |
0.019
|
|
|
|
mrna processing
|
GO:0006397 |
104 |
0.019
|
|
|
|
intracellular transport
|
GO:0046907 |
228 |
0.019
|
|
|
|
chromatin remodeling
|
GO:0006338 |
72 |
0.019
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
12 |
0.019
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
64 |
0.019
|
|
|
|
regulation of protein phosphorylation
|
GO:0001932 |
64 |
0.019
|
|
|
|
cell migration
|
GO:0016477 |
238 |
0.019
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
29 |
0.019
|
|
|
|
axis specification
|
GO:0009798 |
167 |
0.018
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
39 |
0.018
|
|
|
|
regulation of growth
|
GO:0040008 |
233 |
0.018
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
92 |
0.018
|
|
|
|
negative regulation of dna metabolic process
|
GO:0051053 |
12 |
0.018
|
|
|
|
ion transport
|
GO:0006811 |
145 |
0.017
|
|
|
|
epidermis development
|
GO:0008544 |
65 |
0.017
|
|
|
|
cell cycle arrest
|
GO:0007050 |
4 |
0.017
|
|
|
|
positive regulation of response to stimulus
|
GO:0048584 |
323 |
0.017
|
|
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
73 |
0.017
|
|
|
|
dendrite development
|
GO:0016358 |
204 |
0.017
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
0 |
0.017
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
381 |
0.016
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
163 |
0.016
|
|
|
|
oxoacid metabolic process
|
GO:0043436 |
103 |
0.016
|
|
|
|
regulation of transcription from rna polymerase ii promoter
|
GO:0006357 |
378 |
0.016
|
|
|
|
macromolecular complex assembly
|
GO:0065003 |
256 |
0.016
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
36 |
0.016
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
105 |
0.015
|
|
|
|
protein complex biogenesis
|
GO:0070271 |
201 |
0.015
|
|
|
|
multi organism behavior
|
GO:0051705 |
175 |
0.015
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
242 |
0.015
|
|
|
|
regulation of apoptotic process
|
GO:0042981 |
130 |
0.015
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
158 |
0.015
|
|
|
|
rna splicing
|
GO:0008380 |
83 |
0.015
|
|
|
|
response to toxic substance
|
GO:0009636 |
22 |
0.015
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
78 |
0.015
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
89 |
0.015
|
|
|
|
compound eye morphogenesis
|
GO:0001745 |
249 |
0.014
|
|
|
|
germarium derived oocyte fate determination
|
GO:0007294 |
26 |
0.014
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
3 |
0.014
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
27 |
0.014
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
72 |
0.014
|
|
|
|
response to gamma radiation
|
GO:0010332 |
17 |
0.014
|
|
|
|
response to organophosphorus
|
GO:0046683 |
2 |
0.014
|
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
33 |
0.014
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
161 |
0.014
|
|
|
|
regulation of phosphatase activity
|
GO:0010921 |
3 |
0.013
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
4 |
0.013
|
|
|
|
chromatin modification
|
GO:0016568 |
147 |
0.013
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
1 |
0.013
|
|
|
|
positive regulation of molecular function
|
GO:0044093 |
136 |
0.013
|
|
|
|
protein dna complex subunit organization
|
GO:0071824 |
86 |
0.013
|
|
|
|
rna localization
|
GO:0006403 |
115 |
0.013
|
|
|
|
compound eye photoreceptor cell differentiation
|
GO:0001751 |
140 |
0.013
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
73 |
0.013
|
|
|
|
male gamete generation
|
GO:0048232 |
201 |
0.013
|
|
|
|
regulation of double strand break repair via homologous recombination
|
GO:0010569 |
2 |
0.013
|
|
|
|
regulation of cell development
|
GO:0060284 |
215 |
0.013
|
|
|
|
response to alcohol
|
GO:0097305 |
95 |
0.012
|
|
|
|
negative regulation of cell cycle g2 m phase transition
|
GO:1902750 |
8 |
0.012
|
|
|
|
positive regulation of intracellular signal transduction
|
GO:1902533 |
116 |
0.012
|
|
|
|
positive regulation of catalytic activity
|
GO:0043085 |
118 |
0.012
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
47 |
0.012
|
|
|
|
gtp catabolic process
|
GO:0006184 |
72 |
0.012
|
|
|
|
single organism cellular localization
|
GO:1902580 |
180 |
0.012
|
|
|
|
wound healing
|
GO:0042060 |
75 |
0.012
|
|
|
|
protein complex assembly
|
GO:0006461 |
200 |
0.012
|
|
|
|
cell cell signaling involved in cell fate commitment
|
GO:0045168 |
210 |
0.012
|
|
|
|
polarity specification of anterior posterior axis
|
GO:0009949 |
5 |
0.012
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
38 |
0.012
|
|
|
|
proteolysis
|
GO:0006508 |
192 |
0.012
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
28 |
0.011
|
|
|
|
sensory perception
|
GO:0007600 |
196 |
0.011
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
248 |
0.011
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
1 |
0.011
|
|
|
|
organic acid metabolic process
|
GO:0006082 |
103 |
0.011
|
|
|
|
dorsal ventral axis specification
|
GO:0009950 |
66 |
0.011
|
|
|
|
positive regulation of phosphorus metabolic process
|
GO:0010562 |
139 |
0.011
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
109 |
0.011
|
|
|
|
response to wounding
|
GO:0009611 |
94 |
0.011
|
|
|
|
defense response to other organism
|
GO:0098542 |
225 |
0.011
|
|
|
|
negative regulation of nucleobase containing compound metabolic process
|
GO:0045934 |
261 |
0.010
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
63 |
0.010
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
138 |
0.010
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
72 |
0.010
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
206 |
0.010
|
|
|
|
thermotaxis
|
GO:0043052 |
16 |
0.010
|
|
|
|
gtp metabolic process
|
GO:0046039 |
72 |
0.010
|
|
|
|
larval development
|
GO:0002164 |
104 |
0.010
|
|